nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—Upper gastrointestinal haemorrhage—Entecavir—hepatitis B	0.0381	0.112	CcSEcCtD
Bosutinib—Blood amylase increased—Telbivudine—hepatitis B	0.0165	0.0484	CcSEcCtD
Bosutinib—Lipase increased—Telbivudine—hepatitis B	0.0123	0.036	CcSEcCtD
Bosutinib—Abdominal pain lower—Telbivudine—hepatitis B	0.0113	0.0332	CcSEcCtD
Bosutinib—Amylase increased—Telbivudine—hepatitis B	0.00757	0.0222	CcSEcCtD
Bosutinib—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.00736	0.0216	CcSEcCtD
Bosutinib—SYK—blood plasma—hepatitis B	0.00539	0.0232	CbGeAlD
Bosutinib—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00524	0.0154	CcSEcCtD
Bosutinib—Amylase increased—Lamivudine—hepatitis B	0.00427	0.0125	CcSEcCtD
Bosutinib—LYN—blood plasma—hepatitis B	0.00423	0.0182	CbGeAlD
Bosutinib—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.00421	0.0123	CcSEcCtD
Bosutinib—BTK—blood plasma—hepatitis B	0.00415	0.0178	CbGeAlD
Bosutinib—Chest discomfort—Telbivudine—hepatitis B	0.00407	0.0119	CcSEcCtD
Bosutinib—ROCK1—blood plasma—hepatitis B	0.00392	0.0168	CbGeAlD
Bosutinib—BCR—blood plasma—hepatitis B	0.00364	0.0156	CbGeAlD
Bosutinib—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.00356	0.0104	CcSEcCtD
Bosutinib—PTK2B—blood plasma—hepatitis B	0.00329	0.0141	CbGeAlD
Bosutinib—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00326	0.00958	CcSEcCtD
Bosutinib—Respiratory tract infection—Lamivudine—hepatitis B	0.00323	0.00948	CcSEcCtD
Bosutinib—MAP2K2—blood plasma—hepatitis B	0.00312	0.0134	CbGeAlD
Bosutinib—MAP3K2—blood plasma—hepatitis B	0.0031	0.0133	CbGeAlD
Bosutinib—PTK2—blood plasma—hepatitis B	0.00303	0.013	CbGeAlD
Bosutinib—Blood creatinine increased—Entecavir—hepatitis B	0.00298	0.00875	CcSEcCtD
Bosutinib—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00295	0.00866	CcSEcCtD
Bosutinib—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00291	0.00854	CcSEcCtD
Bosutinib—Abdominal pain upper—Entecavir—hepatitis B	0.00291	0.00853	CcSEcCtD
Bosutinib—Renal impairment—Telbivudine—hepatitis B	0.00275	0.00806	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00274	0.00804	CcSEcCtD
Bosutinib—FYN—blood plasma—hepatitis B	0.0027	0.0116	CbGeAlD
Bosutinib—Neutropenia—Entecavir—hepatitis B	0.00257	0.00755	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Entecavir—hepatitis B	0.00256	0.0075	CcSEcCtD
Bosutinib—STK10—blood plasma—hepatitis B	0.00242	0.0104	CbGeAlD
Bosutinib—Acne—Lamivudine—hepatitis B	0.00241	0.00708	CcSEcCtD
Bosutinib—Renal failure—Entecavir—hepatitis B	0.00241	0.00708	CcSEcCtD
Bosutinib—TAOK3—blood plasma—hepatitis B	0.00241	0.0103	CbGeAlD
Bosutinib—Abdominal pain upper—Telbivudine—hepatitis B	0.00239	0.00701	CcSEcCtD
Bosutinib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00236	0.00691	CcSEcCtD
Bosutinib—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00235	0.0069	CcSEcCtD
Bosutinib—SRC—blood plasma—hepatitis B	0.00235	0.0101	CbGeAlD
Bosutinib—Nasopharyngitis—Telbivudine—hepatitis B	0.00234	0.00686	CcSEcCtD
Bosutinib—TLK1—blood—hepatitis B	0.00232	0.00998	CbGeAlD
Bosutinib—Hepatobiliary disease—Entecavir—hepatitis B	0.00232	0.00681	CcSEcCtD
Bosutinib—Gastritis—Telbivudine—hepatitis B	0.00232	0.00679	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00231	0.00677	CcSEcCtD
Bosutinib—PRKCQ—blood—hepatitis B	0.00229	0.00984	CbGeAlD
Bosutinib—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00226	0.00664	CcSEcCtD
Bosutinib—Influenza—Telbivudine—hepatitis B	0.00226	0.00663	CcSEcCtD
Bosutinib—Hepatitis—Entecavir—hepatitis B	0.0022	0.00646	CcSEcCtD
Bosutinib—PKMYT1—blood—hepatitis B	0.0022	0.00946	CbGeAlD
Bosutinib—Oedema peripheral—Entecavir—hepatitis B	0.00217	0.00637	CcSEcCtD
Bosutinib—Abdominal discomfort—Telbivudine—hepatitis B	0.00217	0.00636	CcSEcCtD
Bosutinib—CLK3—blood—hepatitis B	0.00215	0.00923	CbGeAlD
Bosutinib—BMX—blood—hepatitis B	0.00215	0.00923	CbGeAlD
Bosutinib—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00215	0.0063	CcSEcCtD
Bosutinib—BLK—blood—hepatitis B	0.00212	0.00912	CbGeAlD
Bosutinib—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00212	0.00623	CcSEcCtD
Bosutinib—Neutropenia—Telbivudine—hepatitis B	0.00211	0.0062	CcSEcCtD
Bosutinib—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00211	0.0062	CcSEcCtD
Bosutinib—CSF1R—blood plasma—hepatitis B	0.00211	0.00905	CbGeAlD
Bosutinib—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00211	0.00618	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Telbivudine—hepatitis B	0.0021	0.00616	CcSEcCtD
Bosutinib—EIF2AK1—blood—hepatitis B	0.00208	0.00892	CbGeAlD
Bosutinib—TXK—blood—hepatitis B	0.00203	0.00874	CbGeAlD
Bosutinib—FES—blood—hepatitis B	0.00201	0.00865	CbGeAlD
Bosutinib—VRK2—blood—hepatitis B	0.00201	0.00865	CbGeAlD
Bosutinib—Immune system disorder—Entecavir—hepatitis B	0.00199	0.00584	CcSEcCtD
Bosutinib—Renal failure—Telbivudine—hepatitis B	0.00198	0.00581	CcSEcCtD
Bosutinib—TNIK—blood—hepatitis B	0.00198	0.00848	CbGeAlD
Bosutinib—SYK—blood—hepatitis B	0.00198	0.00848	CbGeAlD
Bosutinib—CDK2—blood—hepatitis B	0.00196	0.0084	CbGeAlD
Bosutinib—STK26—blood—hepatitis B	0.00194	0.00833	CbGeAlD
Bosutinib—Malnutrition—Entecavir—hepatitis B	0.00192	0.00562	CcSEcCtD
Bosutinib—Hepatobiliary disease—Telbivudine—hepatitis B	0.00191	0.00559	CcSEcCtD
Bosutinib—CHEK2—blood—hepatitis B	0.00187	0.00804	CbGeAlD
Bosutinib—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00187	0.00549	CcSEcCtD
Bosutinib—WEE1—blood—hepatitis B	0.00186	0.00798	CbGeAlD
Bosutinib—DMPK—blood—hepatitis B	0.00186	0.00798	CbGeAlD
Bosutinib—TLK1—liver—hepatitis B	0.00182	0.0078	CbGeAlD
Bosutinib—Back pain—Adefovir Dipivoxil—hepatitis B	0.00181	0.00531	CcSEcCtD
Bosutinib—Hepatitis—Telbivudine—hepatitis B	0.00181	0.00531	CcSEcCtD
Bosutinib—PRKCQ—liver—hepatitis B	0.00179	0.00769	CbGeAlD
Bosutinib—Connective tissue disorder—Telbivudine—hepatitis B	0.00178	0.00522	CcSEcCtD
Bosutinib—STK25—blood—hepatitis B	0.00177	0.00762	CbGeAlD
Bosutinib—SIK2—liver—hepatitis B	0.00177	0.00759	CbGeAlD
Bosutinib—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00173	0.00507	CcSEcCtD
Bosutinib—PLK2—blood—hepatitis B	0.00172	0.0074	CbGeAlD
Bosutinib—FRK—liver—hepatitis B	0.00172	0.0074	CbGeAlD
Bosutinib—Leukopenia—Entecavir—hepatitis B	0.00172	0.00503	CcSEcCtD
Bosutinib—CLK3—liver—hepatitis B	0.00168	0.00722	CbGeAlD
Bosutinib—STK4—blood—hepatitis B	0.00165	0.00708	CbGeAlD
Bosutinib—CASK—liver—hepatitis B	0.00164	0.00706	CbGeAlD
Bosutinib—Cough—Adefovir Dipivoxil—hepatitis B	0.00163	0.00479	CcSEcCtD
Bosutinib—Mediastinal disorder—Telbivudine—hepatitis B	0.00163	0.00478	CcSEcCtD
Bosutinib—CAMK1D—blood—hepatitis B	0.00163	0.007	CbGeAlD
Bosutinib—EIF2AK1—liver—hepatitis B	0.00163	0.00698	CbGeAlD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00162	0.00476	CcSEcCtD
Bosutinib—STK24—blood—hepatitis B	0.00161	0.00691	CbGeAlD
Bosutinib—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00159	0.00467	CcSEcCtD
Bosutinib—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00159	0.00467	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00158	0.00464	CcSEcCtD
Bosutinib—Malnutrition—Telbivudine—hepatitis B	0.00158	0.00462	CcSEcCtD
Bosutinib—FES—liver—hepatitis B	0.00158	0.00676	CbGeAlD
Bosutinib—VRK2—liver—hepatitis B	0.00158	0.00676	CbGeAlD
Bosutinib—Anaphylactic shock—Entecavir—hepatitis B	0.00157	0.00459	CcSEcCtD
Bosutinib—FER—blood—hepatitis B	0.00156	0.00669	CbGeAlD
Bosutinib—ALK—blood—hepatitis B	0.00156	0.00669	CbGeAlD
Bosutinib—Infection—Entecavir—hepatitis B	0.00155	0.00456	CcSEcCtD
Bosutinib—LYN—blood—hepatitis B	0.00155	0.00666	CbGeAlD
Bosutinib—Renal impairment—Lamivudine—hepatitis B	0.00155	0.00454	CcSEcCtD
Bosutinib—TNIK—liver—hepatitis B	0.00154	0.00663	CbGeAlD
Bosutinib—Dysgeusia—Telbivudine—hepatitis B	0.00154	0.00452	CcSEcCtD
Bosutinib—Nervous system disorder—Entecavir—hepatitis B	0.00153	0.0045	CcSEcCtD
Bosutinib—CDK2—liver—hepatitis B	0.00153	0.00657	CbGeAlD
Bosutinib—MAP4K1—blood—hepatitis B	0.00153	0.00656	CbGeAlD
Bosutinib—Back pain—Telbivudine—hepatitis B	0.00152	0.00447	CcSEcCtD
Bosutinib—Skin disorder—Entecavir—hepatitis B	0.00152	0.00446	CcSEcCtD
Bosutinib—BTK—blood—hepatitis B	0.00152	0.00652	CbGeAlD
Bosutinib—STK26—liver—hepatitis B	0.00152	0.00651	CbGeAlD
Bosutinib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0015	0.00439	CcSEcCtD
Bosutinib—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.0015	0.00439	CcSEcCtD
Bosutinib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00148	0.00435	CcSEcCtD
Bosutinib—MAP4K2—blood—hepatitis B	0.00148	0.00634	CbGeAlD
Bosutinib—Ill-defined disorder—Telbivudine—hepatitis B	0.00146	0.00429	CcSEcCtD
Bosutinib—STK3—blood—hepatitis B	0.00146	0.00625	CbGeAlD
Bosutinib—DMPK—liver—hepatitis B	0.00145	0.00624	CbGeAlD
Bosutinib—WEE1—liver—hepatitis B	0.00145	0.00624	CbGeAlD
Bosutinib—ROCK1—blood—hepatitis B	0.00144	0.00617	CbGeAlD
Bosutinib—Malaise—Telbivudine—hepatitis B	0.00142	0.00417	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00139	0.00408	CcSEcCtD
Bosutinib—STK25—liver—hepatitis B	0.00139	0.00596	CbGeAlD
Bosutinib—STK36—blood—hepatitis B	0.00139	0.00595	CbGeAlD
Bosutinib—Cough—Telbivudine—hepatitis B	0.00137	0.00403	CcSEcCtD
Bosutinib—Dehydration—Lamivudine—hepatitis B	0.00137	0.00402	CcSEcCtD
Bosutinib—MERTK—blood—hepatitis B	0.00137	0.00588	CbGeAlD
Bosutinib—Gastrointestinal disorder—Entecavir—hepatitis B	0.00135	0.00396	CcSEcCtD
Bosutinib—Fatigue—Entecavir—hepatitis B	0.00135	0.00396	CcSEcCtD
Bosutinib—PLK2—liver—hepatitis B	0.00135	0.00579	CbGeAlD
Bosutinib—Abdominal pain upper—Lamivudine—hepatitis B	0.00135	0.00395	CcSEcCtD
Bosutinib—MAP4K4—blood—hepatitis B	0.00134	0.00577	CbGeAlD
Bosutinib—Myalgia—Telbivudine—hepatitis B	0.00134	0.00393	CcSEcCtD
Bosutinib—Arthralgia—Telbivudine—hepatitis B	0.00134	0.00393	CcSEcCtD
Bosutinib—Chest pain—Telbivudine—hepatitis B	0.00134	0.00393	CcSEcCtD
Bosutinib—SIK3—liver—hepatitis B	0.00134	0.00575	CbGeAlD
Bosutinib—NUAK2—blood—hepatitis B	0.00133	0.00573	CbGeAlD
Bosutinib—BCR—blood—hepatitis B	0.00133	0.00573	CbGeAlD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00133	0.00391	CcSEcCtD
Bosutinib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00133	0.00389	CcSEcCtD
Bosutinib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00133	0.00389	CcSEcCtD
Bosutinib—Discomfort—Telbivudine—hepatitis B	0.00133	0.00389	CcSEcCtD
Bosutinib—MAP3K12—blood—hepatitis B	0.00132	0.00569	CbGeAlD
Bosutinib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00132	0.00387	CcSEcCtD
Bosutinib—Nasopharyngitis—Lamivudine—hepatitis B	0.00132	0.00387	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.0013	0.00381	CcSEcCtD
Bosutinib—MAP2K1—blood—hepatitis B	0.0013	0.00557	CbGeAlD
Bosutinib—CSK—blood—hepatitis B	0.00129	0.00554	CbGeAlD
Bosutinib—STK4—liver—hepatitis B	0.00129	0.00554	CbGeAlD
Bosutinib—CSNK1A1—blood—hepatitis B	0.00128	0.0055	CbGeAlD
Bosutinib—Gastrointestinal pain—Entecavir—hepatitis B	0.00128	0.00375	CcSEcCtD
Bosutinib—Influenza—Lamivudine—hepatitis B	0.00127	0.00374	CcSEcCtD
Bosutinib—CAMK1D—liver—hepatitis B	0.00127	0.00547	CbGeAlD
Bosutinib—HCK—blood—hepatitis B	0.00127	0.00547	CbGeAlD
Bosutinib—CLK1—blood—hepatitis B	0.00127	0.00547	CbGeAlD
Bosutinib—ABL2—blood—hepatitis B	0.00126	0.00543	CbGeAlD
Bosutinib—Nervous system disorder—Telbivudine—hepatitis B	0.00126	0.0037	CcSEcCtD
Bosutinib—STK24—liver—hepatitis B	0.00126	0.00541	CbGeAlD
Bosutinib—Thrombocytopenia—Telbivudine—hepatitis B	0.00126	0.00369	CcSEcCtD
Bosutinib—CAMK2G—blood—hepatitis B	0.00125	0.00537	CbGeAlD
Bosutinib—BMP2K—blood—hepatitis B	0.00125	0.00537	CbGeAlD
Bosutinib—Skin disorder—Telbivudine—hepatitis B	0.00125	0.00366	CcSEcCtD
Bosutinib—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00125	0.00366	CcSEcCtD
Bosutinib—LRRK2—blood—hepatitis B	0.00124	0.00532	CbGeAlD
Bosutinib—Body temperature increased—Entecavir—hepatitis B	0.00124	0.00363	CcSEcCtD
Bosutinib—Abdominal pain—Entecavir—hepatitis B	0.00124	0.00363	CcSEcCtD
Bosutinib—Bronchitis—Lamivudine—hepatitis B	0.00123	0.00359	CcSEcCtD
Bosutinib—Abdominal discomfort—Lamivudine—hepatitis B	0.00122	0.00358	CcSEcCtD
Bosutinib—FER—liver—hepatitis B	0.00122	0.00523	CbGeAlD
Bosutinib—LYN—liver—hepatitis B	0.00121	0.00521	CbGeAlD
Bosutinib—Pancytopenia—Lamivudine—hepatitis B	0.00121	0.00355	CcSEcCtD
Bosutinib—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00121	0.00354	CcSEcCtD
Bosutinib—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00121	0.00354	CcSEcCtD
Bosutinib—PTK2B—blood—hepatitis B	0.00121	0.00518	CbGeAlD
Bosutinib—Neutropenia—Lamivudine—hepatitis B	0.00119	0.00349	CcSEcCtD
Bosutinib—BTK—liver—hepatitis B	0.00119	0.0051	CbGeAlD
Bosutinib—CSNK1E—blood—hepatitis B	0.00119	0.0051	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00117	0.00344	CcSEcCtD
Bosutinib—TNK2—liver—hepatitis B	0.00117	0.00503	CbGeAlD
Bosutinib—SIK1—blood—hepatitis B	0.00117	0.00502	CbGeAlD
Bosutinib—IRAK4—blood—hepatitis B	0.00117	0.00502	CbGeAlD
Bosutinib—EPHA4—blood—hepatitis B	0.00116	0.00497	CbGeAlD
Bosutinib—MAP4K2—liver—hepatitis B	0.00115	0.00496	CbGeAlD
Bosutinib—ULK3—blood—hepatitis B	0.00114	0.00491	CbGeAlD
Bosutinib—MAP2K2—blood—hepatitis B	0.00114	0.00491	CbGeAlD
Bosutinib—STK3—liver—hepatitis B	0.00114	0.00489	CbGeAlD
Bosutinib—MAP3K2—blood—hepatitis B	0.00113	0.00487	CbGeAlD
Bosutinib—ROCK1—liver—hepatitis B	0.00112	0.00483	CbGeAlD
Bosutinib—MAP3K7—blood—hepatitis B	0.00112	0.00483	CbGeAlD
Bosutinib—Asthenia—Entecavir—hepatitis B	0.00112	0.00329	CcSEcCtD
Bosutinib—Renal failure—Lamivudine—hepatitis B	0.00112	0.00328	CcSEcCtD
Bosutinib—PTK2—blood—hepatitis B	0.00111	0.00477	CbGeAlD
Bosutinib—TBK1—blood—hepatitis B	0.00111	0.00477	CbGeAlD
Bosutinib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00111	0.00326	CcSEcCtD
Bosutinib—Fatigue—Telbivudine—hepatitis B	0.00111	0.00325	CcSEcCtD
Bosutinib—Pain—Telbivudine—hepatitis B	0.0011	0.00322	CcSEcCtD
Bosutinib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.0011	0.00321	CcSEcCtD
Bosutinib—BMPR2—liver—hepatitis B	0.00109	0.00469	CbGeAlD
Bosutinib—IRAK1—blood—hepatitis B	0.00109	0.00468	CbGeAlD
Bosutinib—STK36—liver—hepatitis B	0.00108	0.00465	CbGeAlD
Bosutinib—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00108	0.00317	CcSEcCtD
Bosutinib—Hepatobiliary disease—Lamivudine—hepatitis B	0.00107	0.00315	CcSEcCtD
Bosutinib—Diarrhoea—Entecavir—hepatitis B	0.00107	0.00314	CcSEcCtD
Bosutinib—MERTK—liver—hepatitis B	0.00107	0.0046	CbGeAlD
Bosutinib—RPS6KB1—blood—hepatitis B	0.00107	0.00459	CbGeAlD
Bosutinib—FGR—blood—hepatitis B	0.00106	0.00456	CbGeAlD
Bosutinib—LCK—blood—hepatitis B	0.00106	0.00456	CbGeAlD
Bosutinib—Agranulocytosis—Lamivudine—hepatitis B	0.00106	0.00311	CcSEcCtD
Bosutinib—Feeling abnormal—Telbivudine—hepatitis B	0.00106	0.00311	CcSEcCtD
Bosutinib—Gastrointestinal pain—Telbivudine—hepatitis B	0.00105	0.00308	CcSEcCtD
Bosutinib—MAP4K4—liver—hepatitis B	0.00105	0.00451	CbGeAlD
Bosutinib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00104	0.00306	CcSEcCtD
Bosutinib—NUAK2—liver—hepatitis B	0.00104	0.00448	CbGeAlD
Bosutinib—BCR—liver—hepatitis B	0.00104	0.00448	CbGeAlD
Bosutinib—MAP3K12—liver—hepatitis B	0.00104	0.00445	CbGeAlD
Bosutinib—Dizziness—Entecavir—hepatitis B	0.00103	0.00304	CcSEcCtD
Bosutinib—Hepatitis—Lamivudine—hepatitis B	0.00102	0.00299	CcSEcCtD
Bosutinib—SLK—blood—hepatitis B	0.00102	0.00437	CbGeAlD
Bosutinib—Abdominal pain—Telbivudine—hepatitis B	0.00102	0.00298	CcSEcCtD
Bosutinib—Body temperature increased—Telbivudine—hepatitis B	0.00102	0.00298	CcSEcCtD
Bosutinib—MAP2K1—liver—hepatitis B	0.00102	0.00436	CbGeAlD
Bosutinib—STK35—liver—hepatitis B	0.00102	0.00436	CbGeAlD
Bosutinib—EPHB4—blood—hepatitis B	0.00101	0.00434	CbGeAlD
Bosutinib—CSK—liver—hepatitis B	0.00101	0.00433	CbGeAlD
Bosutinib—Connective tissue disorder—Lamivudine—hepatitis B	0.001	0.00294	CcSEcCtD
Bosutinib—CSNK1A1—liver—hepatitis B	0.001	0.0043	CbGeAlD
Bosutinib—HCK—liver—hepatitis B	0.000995	0.00427	CbGeAlD
Bosutinib—CLK1—liver—hepatitis B	0.000995	0.00427	CbGeAlD
Bosutinib—Vomiting—Entecavir—hepatitis B	0.000995	0.00292	CcSEcCtD
Bosutinib—EPHA2—blood—hepatitis B	0.000992	0.00426	CbGeAlD
Bosutinib—FYN—blood—hepatitis B	0.00099	0.00425	CbGeAlD
Bosutinib—ABL2—liver—hepatitis B	0.000989	0.00425	CbGeAlD
Bosutinib—Rash—Entecavir—hepatitis B	0.000987	0.00289	CcSEcCtD
Bosutinib—Dermatitis—Entecavir—hepatitis B	0.000986	0.00289	CcSEcCtD
Bosutinib—Headache—Entecavir—hepatitis B	0.00098	0.00288	CcSEcCtD
Bosutinib—BMP2K—liver—hepatitis B	0.000977	0.0042	CbGeAlD
Bosutinib—CAMK2G—liver—hepatitis B	0.000977	0.0042	CbGeAlD
Bosutinib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000971	0.00285	CcSEcCtD
Bosutinib—LRRK2—liver—hepatitis B	0.000968	0.00416	CbGeAlD
Bosutinib—MAP4K5—blood—hepatitis B	0.000968	0.00416	CbGeAlD
Bosutinib—MAP3K3—blood—hepatitis B	0.000968	0.00416	CbGeAlD
Bosutinib—EGFR—liver—hepatitis B	0.000965	0.00415	CbGeAlD
Bosutinib—Erythema multiforme—Lamivudine—hepatitis B	0.000964	0.00283	CcSEcCtD
Bosutinib—Rash—Adefovir Dipivoxil—hepatitis B	0.000963	0.00282	CcSEcCtD
Bosutinib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000962	0.00282	CcSEcCtD
Bosutinib—Headache—Adefovir Dipivoxil—hepatitis B	0.000957	0.00281	CcSEcCtD
Bosutinib—PTK2B—liver—hepatitis B	0.000944	0.00405	CbGeAlD
Bosutinib—Nausea—Entecavir—hepatitis B	0.00093	0.00273	CcSEcCtD
Bosutinib—CSNK1E—liver—hepatitis B	0.000928	0.00399	CbGeAlD
Bosutinib—Asthenia—Telbivudine—hepatitis B	0.000922	0.00271	CcSEcCtD
Bosutinib—Immune system disorder—Lamivudine—hepatitis B	0.000921	0.0027	CcSEcCtD
Bosutinib—Mediastinal disorder—Lamivudine—hepatitis B	0.000919	0.0027	CcSEcCtD
Bosutinib—SIK1—liver—hepatitis B	0.000914	0.00392	CbGeAlD
Bosutinib—IRAK4—liver—hepatitis B	0.000914	0.00392	CbGeAlD
Bosutinib—Pruritus—Telbivudine—hepatitis B	0.00091	0.00267	CcSEcCtD
Bosutinib—Nausea—Adefovir Dipivoxil—hepatitis B	0.000907	0.00266	CcSEcCtD
Bosutinib—ERBB3—liver—hepatitis B	0.000896	0.00385	CbGeAlD
Bosutinib—YES1—blood—hepatitis B	0.000894	0.00384	CbGeAlD
Bosutinib—ULK3—liver—hepatitis B	0.000894	0.00384	CbGeAlD
Bosutinib—MAP2K2—liver—hepatitis B	0.000894	0.00384	CbGeAlD
Bosutinib—Malnutrition—Lamivudine—hepatitis B	0.000888	0.0026	CcSEcCtD
Bosutinib—MAP3K2—liver—hepatitis B	0.000887	0.00381	CbGeAlD
Bosutinib—STK10—blood—hepatitis B	0.000886	0.0038	CbGeAlD
Bosutinib—TAOK3—blood—hepatitis B	0.000882	0.00379	CbGeAlD
Bosutinib—Diarrhoea—Telbivudine—hepatitis B	0.00088	0.00258	CcSEcCtD
Bosutinib—MAP3K7—liver—hepatitis B	0.000879	0.00377	CbGeAlD
Bosutinib—Dysgeusia—Lamivudine—hepatitis B	0.000869	0.00255	CcSEcCtD
Bosutinib—PTK2—liver—hepatitis B	0.000869	0.00373	CbGeAlD
Bosutinib—TBK1—liver—hepatitis B	0.000869	0.00373	CbGeAlD
Bosutinib—SRC—blood—hepatitis B	0.00086	0.00369	CbGeAlD
Bosutinib—Back pain—Lamivudine—hepatitis B	0.000859	0.00252	CcSEcCtD
Bosutinib—IRAK1—liver—hepatitis B	0.000852	0.00366	CbGeAlD
Bosutinib—Dizziness—Telbivudine—hepatitis B	0.00085	0.00249	CcSEcCtD
Bosutinib—RPS6KB1—liver—hepatitis B	0.000836	0.00359	CbGeAlD
Bosutinib—LCK—liver—hepatitis B	0.000831	0.00357	CbGeAlD
Bosutinib—FGR—liver—hepatitis B	0.000831	0.00357	CbGeAlD
Bosutinib—AXL—liver—hepatitis B	0.000827	0.00355	CbGeAlD
Bosutinib—Ill-defined disorder—Lamivudine—hepatitis B	0.000824	0.00242	CcSEcCtD
Bosutinib—Anaemia—Lamivudine—hepatitis B	0.000821	0.00241	CcSEcCtD
Bosutinib—Vomiting—Telbivudine—hepatitis B	0.000817	0.0024	CcSEcCtD
Bosutinib—Rash—Telbivudine—hepatitis B	0.000811	0.00238	CcSEcCtD
Bosutinib—Dermatitis—Telbivudine—hepatitis B	0.00081	0.00238	CcSEcCtD
Bosutinib—Headache—Telbivudine—hepatitis B	0.000805	0.00236	CcSEcCtD
Bosutinib—Malaise—Lamivudine—hepatitis B	0.000801	0.00235	CcSEcCtD
Bosutinib—SLK—liver—hepatitis B	0.000796	0.00342	CbGeAlD
Bosutinib—Leukopenia—Lamivudine—hepatitis B	0.000795	0.00233	CcSEcCtD
Bosutinib—MAP2K5—blood—hepatitis B	0.000791	0.0034	CbGeAlD
Bosutinib—EPHB4—liver—hepatitis B	0.000791	0.0034	CbGeAlD
Bosutinib—EPHA2—liver—hepatitis B	0.000776	0.00333	CbGeAlD
Bosutinib—Cough—Lamivudine—hepatitis B	0.000775	0.00227	CcSEcCtD
Bosutinib—FYN—liver—hepatitis B	0.000774	0.00333	CbGeAlD
Bosutinib—CSF1R—blood—hepatitis B	0.000772	0.00331	CbGeAlD
Bosutinib—Nausea—Telbivudine—hepatitis B	0.000764	0.00224	CcSEcCtD
Bosutinib—MAP4K5—liver—hepatitis B	0.000757	0.00325	CbGeAlD
Bosutinib—MAP3K3—liver—hepatitis B	0.000757	0.00325	CbGeAlD
Bosutinib—Arthralgia—Lamivudine—hepatitis B	0.000756	0.00222	CcSEcCtD
Bosutinib—Chest pain—Lamivudine—hepatitis B	0.000756	0.00222	CcSEcCtD
Bosutinib—Myalgia—Lamivudine—hepatitis B	0.000756	0.00222	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000751	0.0022	CcSEcCtD
Bosutinib—Discomfort—Lamivudine—hepatitis B	0.000747	0.00219	CcSEcCtD
Bosutinib—CYP3A4—blood plasma—hepatitis B	0.000732	0.00314	CbGeAlD
Bosutinib—Anaphylactic shock—Lamivudine—hepatitis B	0.000725	0.00213	CcSEcCtD
Bosutinib—Oedema—Lamivudine—hepatitis B	0.000725	0.00213	CcSEcCtD
Bosutinib—Infection—Lamivudine—hepatitis B	0.00072	0.00211	CcSEcCtD
Bosutinib—Nervous system disorder—Lamivudine—hepatitis B	0.000711	0.00208	CcSEcCtD
Bosutinib—Thrombocytopenia—Lamivudine—hepatitis B	0.000709	0.00208	CcSEcCtD
Bosutinib—Skin disorder—Lamivudine—hepatitis B	0.000704	0.00206	CcSEcCtD
Bosutinib—YES1—liver—hepatitis B	0.000699	0.003	CbGeAlD
Bosutinib—Vandetanib—ALB—hepatitis B	0.000693	0.513	CrCbGaD
Bosutinib—STK10—liver—hepatitis B	0.000693	0.00297	CbGeAlD
Bosutinib—TAOK3—liver—hepatitis B	0.00069	0.00296	CbGeAlD
Bosutinib—PDGFRB—blood—hepatitis B	0.000685	0.00294	CbGeAlD
Bosutinib—SRC—liver—hepatitis B	0.000672	0.00289	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00066	0.00194	CcSEcCtD
Bosutinib—Gefitinib—ALB—hepatitis B	0.000658	0.487	CrCbGaD
Bosutinib—Dyspnoea—Lamivudine—hepatitis B	0.000646	0.00189	CcSEcCtD
Bosutinib—Decreased appetite—Lamivudine—hepatitis B	0.00063	0.00185	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000626	0.00183	CcSEcCtD
Bosutinib—Fatigue—Lamivudine—hepatitis B	0.000625	0.00183	CcSEcCtD
Bosutinib—Pain—Lamivudine—hepatitis B	0.00062	0.00182	CcSEcCtD
Bosutinib—MAP2K5—liver—hepatitis B	0.000619	0.00266	CbGeAlD
Bosutinib—ABL1—blood—hepatitis B	0.00061	0.00262	CbGeAlD
Bosutinib—CSF1R—liver—hepatitis B	0.000604	0.00259	CbGeAlD
Bosutinib—Feeling abnormal—Lamivudine—hepatitis B	0.000597	0.00175	CcSEcCtD
Bosutinib—Gastrointestinal pain—Lamivudine—hepatitis B	0.000593	0.00174	CcSEcCtD
Bosutinib—Urticaria—Lamivudine—hepatitis B	0.000576	0.00169	CcSEcCtD
Bosutinib—Abdominal pain—Lamivudine—hepatitis B	0.000573	0.00168	CcSEcCtD
Bosutinib—Body temperature increased—Lamivudine—hepatitis B	0.000573	0.00168	CcSEcCtD
Bosutinib—PDGFRB—liver—hepatitis B	0.000535	0.0023	CbGeAlD
Bosutinib—Asthenia—Lamivudine—hepatitis B	0.00052	0.00152	CcSEcCtD
Bosutinib—ABCB1—blood plasma—hepatitis B	0.000518	0.00222	CbGeAlD
Bosutinib—Pruritus—Lamivudine—hepatitis B	0.000513	0.0015	CcSEcCtD
Bosutinib—Diarrhoea—Lamivudine—hepatitis B	0.000496	0.00145	CcSEcCtD
Bosutinib—Dizziness—Lamivudine—hepatitis B	0.000479	0.00141	CcSEcCtD
Bosutinib—ABL1—liver—hepatitis B	0.000477	0.00205	CbGeAlD
Bosutinib—Vomiting—Lamivudine—hepatitis B	0.000461	0.00135	CcSEcCtD
Bosutinib—Rash—Lamivudine—hepatitis B	0.000457	0.00134	CcSEcCtD
Bosutinib—Dermatitis—Lamivudine—hepatitis B	0.000456	0.00134	CcSEcCtD
Bosutinib—Headache—Lamivudine—hepatitis B	0.000454	0.00133	CcSEcCtD
Bosutinib—Nausea—Lamivudine—hepatitis B	0.00043	0.00126	CcSEcCtD
Bosutinib—CYP3A4—blood—hepatitis B	0.000268	0.00115	CbGeAlD
Bosutinib—CYP3A4—liver—hepatitis B	0.00021	0.0009	CbGeAlD
Bosutinib—ABCB1—blood—hepatitis B	0.00019	0.000815	CbGeAlD
Bosutinib—ABCB1—liver—hepatitis B	0.000148	0.000637	CbGeAlD
Bosutinib—MAP2K5—Signaling Pathways—PTEN—hepatitis B	5.75e-06	1.35e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CDKN1A—hepatitis B	5.74e-06	1.35e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—PTEN—hepatitis B	5.73e-06	1.35e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—IL6—hepatitis B	5.73e-06	1.35e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CTNNB1—hepatitis B	5.73e-06	1.35e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—F2—hepatitis B	5.72e-06	1.35e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—NFKB1—hepatitis B	5.72e-06	1.35e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—NFKB1—hepatitis B	5.72e-06	1.35e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IFNG—hepatitis B	5.71e-06	1.34e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—NFKB1—hepatitis B	5.7e-06	1.34e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—CTNNB1—hepatitis B	5.69e-06	1.34e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCR5—hepatitis B	5.67e-06	1.34e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CTNNB1—hepatitis B	5.67e-06	1.33e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CTNNB1—hepatitis B	5.64e-06	1.33e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—F2—hepatitis B	5.64e-06	1.33e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—IL6—hepatitis B	5.62e-06	1.32e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—IL6—hepatitis B	5.62e-06	1.32e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CDKN1A—hepatitis B	5.62e-06	1.32e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—PTEN—hepatitis B	5.61e-06	1.32e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—IL6—hepatitis B	5.61e-06	1.32e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—F2—hepatitis B	5.6e-06	1.32e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CDKN1A—hepatitis B	5.6e-06	1.32e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—PTEN—hepatitis B	5.58e-06	1.31e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—NFKB1—hepatitis B	5.58e-06	1.31e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—CTNNB1—hepatitis B	5.56e-06	1.31e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—NFKB1—hepatitis B	5.56e-06	1.31e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—CDKN1A—hepatitis B	5.55e-06	1.31e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL2—hepatitis B	5.55e-06	1.31e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—PTEN—hepatitis B	5.54e-06	1.3e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CDKN1A—hepatitis B	5.54e-06	1.3e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—PTEN—hepatitis B	5.52e-06	1.3e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—NFKB1—hepatitis B	5.51e-06	1.3e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD4—hepatitis B	5.51e-06	1.3e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CDKN1A—hepatitis B	5.51e-06	1.3e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IFNG—hepatitis B	5.5e-06	1.29e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—NFKB1—hepatitis B	5.5e-06	1.29e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—PTEN—hepatitis B	5.49e-06	1.29e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCR5—hepatitis B	5.47e-06	1.29e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—NFKB1—hepatitis B	5.47e-06	1.29e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—CDKN1A—hepatitis B	5.43e-06	1.28e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—IL6—hepatitis B	5.43e-06	1.28e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CTNNB1—hepatitis B	5.43e-06	1.28e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—PTEN—hepatitis B	5.42e-06	1.28e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—IL6—hepatitis B	5.35e-06	1.26e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GOT2—hepatitis B	5.32e-06	1.25e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD4—hepatitis B	5.31e-06	1.25e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CDKN1A—hepatitis B	5.3e-06	1.25e-05	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—TP53—hepatitis B	5.3e-06	1.25e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—PTEN—hepatitis B	5.29e-06	1.25e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL2—hepatitis B	5.24e-06	1.23e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—CTNNB1—hepatitis B	5.23e-06	1.23e-05	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	5.21e-06	1.23e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TGFB1—hepatitis B	5.21e-06	1.23e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CTNNB1—hepatitis B	5.2e-06	1.22e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL2—hepatitis B	5.17e-06	1.22e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TGFB1—hepatitis B	5.14e-06	1.21e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—IL6—hepatitis B	5.12e-06	1.2e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—CDKN1A—hepatitis B	5.11e-06	1.2e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—PTEN—hepatitis B	5.1e-06	1.2e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD4—hepatitis B	5.09e-06	1.2e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CDKN1A—hepatitis B	5.08e-06	1.2e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—PTEN—hepatitis B	5.07e-06	1.19e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL2—hepatitis B	5.07e-06	1.19e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CTNNB1—hepatitis B	5.06e-06	1.19e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CTNNB1—hepatitis B	4.99e-06	1.17e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—TP53—hepatitis B	4.96e-06	1.17e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TGFB1—hepatitis B	4.95e-06	1.16e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—IL6—hepatitis B	4.94e-06	1.16e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CDKN1A—hepatitis B	4.94e-06	1.16e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—IL6—hepatitis B	4.94e-06	1.16e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—PTEN—hepatitis B	4.93e-06	1.16e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—IL6—hepatitis B	4.93e-06	1.16e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—NFKB1—hepatitis B	4.91e-06	1.16e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CD4—hepatitis B	4.9e-06	1.15e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL2—hepatitis B	4.9e-06	1.15e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CTNNB1—hepatitis B	4.9e-06	1.15e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL2—hepatitis B	4.89e-06	1.15e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CDKN1A—hepatitis B	4.88e-06	1.15e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IFNG—hepatitis B	4.87e-06	1.15e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—F2—hepatitis B	4.87e-06	1.15e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—PTEN—hepatitis B	4.86e-06	1.14e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR5—hepatitis B	4.84e-06	1.14e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—NFKB1—hepatitis B	4.84e-06	1.14e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CDKN1A—hepatitis B	4.78e-06	1.13e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—PTEN—hepatitis B	4.77e-06	1.12e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFB1—hepatitis B	4.77e-06	1.12e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFB1—hepatitis B	4.77e-06	1.12e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—hepatitis B	4.77e-06	1.12e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—NFKB1—hepatitis B	4.75e-06	1.12e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CTNNB1—hepatitis B	4.73e-06	1.11e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CTNNB1—hepatitis B	4.72e-06	1.11e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD4—hepatitis B	4.7e-06	1.11e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—hepatitis B	4.7e-06	1.11e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—F2—hepatitis B	4.69e-06	1.1e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CDKN1A—hepatitis B	4.62e-06	1.09e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL2—hepatitis B	4.62e-06	1.09e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—PTEN—hepatitis B	4.61e-06	1.09e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CDKN1A—hepatitis B	4.61e-06	1.08e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—PTEN—hepatitis B	4.6e-06	1.08e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFB1—hepatitis B	4.59e-06	1.08e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—NFKB1—hepatitis B	4.59e-06	1.08e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GGT1—hepatitis B	4.59e-06	1.08e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GOT1—hepatitis B	4.59e-06	1.08e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—NFKB1—hepatitis B	4.58e-06	1.08e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—hepatitis B	4.54e-06	1.07e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CTNNB1—hepatitis B	4.52e-06	1.06e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFB1—hepatitis B	4.49e-06	1.06e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—hepatitis B	4.46e-06	1.05e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CTNNB1—hepatitis B	4.46e-06	1.05e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CDKN1A—hepatitis B	4.42e-06	1.04e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—PTEN—hepatitis B	4.41e-06	1.04e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFB1—hepatitis B	4.39e-06	1.03e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—hepatitis B	4.37e-06	1.03e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CTNNB1—hepatitis B	4.36e-06	1.03e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CDKN1A—hepatitis B	4.35e-06	1.02e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—PTEN—hepatitis B	4.34e-06	1.02e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CD4—hepatitis B	4.34e-06	1.02e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL2—hepatitis B	4.33e-06	1.02e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—NFKB1—hepatitis B	4.32e-06	1.02e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TP53—hepatitis B	4.29e-06	1.01e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CDKN1A—hepatitis B	4.25e-06	1e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—PTEN—hepatitis B	4.25e-06	9.99e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TP53—hepatitis B	4.23e-06	9.95e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFB1—hepatitis B	4.23e-06	9.95e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFB1—hepatitis B	4.2e-06	9.9e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—hepatitis B	4.2e-06	9.88e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—CTNNB1—hepatitis B	4.18e-06	9.83e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—F2—hepatitis B	4.15e-06	9.78e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFB1—hepatitis B	4.09e-06	9.62e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—CDKN1A—hepatitis B	4.08e-06	9.6e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TP53—hepatitis B	4.07e-06	9.59e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—PTEN—hepatitis B	4.07e-06	9.58e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—NFKB1—hepatitis B	4.05e-06	9.54e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL2—hepatitis B	4.03e-06	9.5e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFB1—hepatitis B	4.03e-06	9.49e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—hepatitis B	4.01e-06	9.45e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL2—hepatitis B	3.94e-06	9.27e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—hepatitis B	3.93e-06	9.24e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TP53—hepatitis B	3.92e-06	9.23e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TP53—hepatitis B	3.92e-06	9.23e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CTNNB1—hepatitis B	3.89e-06	9.17e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—hepatitis B	3.87e-06	9.11e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—CTNNB1—hepatitis B	3.86e-06	9.08e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL2—hepatitis B	3.85e-06	9.07e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFB1—hepatitis B	3.82e-06	9e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CDKN1A—hepatitis B	3.8e-06	8.96e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CTNNB1—hepatitis B	3.8e-06	8.95e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—PTEN—hepatitis B	3.8e-06	8.94e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL2—hepatitis B	3.79e-06	8.93e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TP53—hepatitis B	3.78e-06	8.9e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NFKB1—hepatitis B	3.78e-06	8.89e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL2—hepatitis B	3.77e-06	8.88e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—CDKN1A—hepatitis B	3.77e-06	8.87e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—PTEN—hepatitis B	3.76e-06	8.85e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—hepatitis B	3.76e-06	8.84e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—hepatitis B	3.73e-06	8.77e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CTNNB1—hepatitis B	3.72e-06	8.76e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CDKN1A—hepatitis B	3.71e-06	8.74e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—PTEN—hepatitis B	3.7e-06	8.72e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NFKB1—hepatitis B	3.69e-06	8.68e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—hepatitis B	3.67e-06	8.63e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CTNNB1—hepatitis B	3.66e-06	8.62e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—hepatitis B	3.65e-06	8.6e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CTNNB1—hepatitis B	3.64e-06	8.58e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CDKN1A—hepatitis B	3.64e-06	8.56e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—PTEN—hepatitis B	3.63e-06	8.54e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2A6—hepatitis B	3.62e-06	8.52e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NFKB1—hepatitis B	3.61e-06	8.5e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—hepatitis B	3.6e-06	8.48e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—hepatitis B	3.59e-06	8.45e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—hepatitis B	3.59e-06	8.45e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—hepatitis B	3.58e-06	8.42e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CDKN1A—hepatitis B	3.58e-06	8.42e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—PTEN—hepatitis B	3.57e-06	8.4e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CDKN1A—hepatitis B	3.56e-06	8.38e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NFKB1—hepatitis B	3.55e-06	8.36e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—PTEN—hepatitis B	3.55e-06	8.36e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NFKB1—hepatitis B	3.53e-06	8.32e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—hepatitis B	3.52e-06	8.28e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—hepatitis B	3.5e-06	8.25e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—hepatitis B	3.49e-06	8.21e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—hepatitis B	3.46e-06	8.15e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—hepatitis B	3.45e-06	8.12e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—hepatitis B	3.43e-06	8.08e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—hepatitis B	3.39e-06	7.97e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TP53—hepatitis B	3.37e-06	7.92e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TP53—hepatitis B	3.32e-06	7.81e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—hepatitis B	3.3e-06	7.78e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL2—hepatitis B	3.28e-06	7.72e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GOT2—hepatitis B	3.27e-06	7.71e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—hepatitis B	3.26e-06	7.68e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—hepatitis B	3.19e-06	7.5e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—hepatitis B	3.17e-06	7.46e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CTNNB1—hepatitis B	3.16e-06	7.45e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL2—hepatitis B	3.16e-06	7.44e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TP53—hepatitis B	3.15e-06	7.41e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—hepatitis B	3.15e-06	7.41e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—hepatitis B	3.12e-06	7.33e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CDKN1A—hepatitis B	3.09e-06	7.28e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—PTEN—hepatitis B	3.08e-06	7.26e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—hepatitis B	3.08e-06	7.25e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—hepatitis B	3.07e-06	7.23e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NFKB1—hepatitis B	3.07e-06	7.23e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CTNNB1—hepatitis B	3.05e-06	7.18e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—hepatitis B	3.04e-06	7.15e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—hepatitis B	3.01e-06	7.08e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—hepatitis B	2.98e-06	7.02e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CDKN1A—hepatitis B	2.98e-06	7.01e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—PTEN—hepatitis B	2.97e-06	7e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TP53—hepatitis B	2.96e-06	6.98e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—hepatitis B	2.96e-06	6.97e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NFKB1—hepatitis B	2.96e-06	6.96e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—hepatitis B	2.94e-06	6.93e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—hepatitis B	2.88e-06	6.78e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—hepatitis B	2.87e-06	6.76e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GGT1—hepatitis B	2.83e-06	6.65e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GOT1—hepatitis B	2.83e-06	6.65e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2—hepatitis B	2.8e-06	6.58e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—hepatitis B	2.75e-06	6.48e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—hepatitis B	2.71e-06	6.39e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CTNNB1—hepatitis B	2.7e-06	6.36e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—hepatitis B	2.65e-06	6.24e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CDKN1A—hepatitis B	2.64e-06	6.21e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PTEN—hepatitis B	2.63e-06	6.19e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NFKB1—hepatitis B	2.62e-06	6.16e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TP53—hepatitis B	2.59e-06	6.1e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—hepatitis B	2.56e-06	6.02e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—hepatitis B	2.54e-06	5.99e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TP53—hepatitis B	2.53e-06	5.95e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TP53—hepatitis B	2.48e-06	5.83e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—hepatitis B	2.46e-06	5.8e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ALB—hepatitis B	2.44e-06	5.74e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TP53—hepatitis B	2.44e-06	5.74e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TP53—hepatitis B	2.42e-06	5.71e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—hepatitis B	2.37e-06	5.58e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—hepatitis B	2.35e-06	5.53e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—hepatitis B	2.31e-06	5.45e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—hepatitis B	2.27e-06	5.33e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—hepatitis B	2.23e-06	5.25e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—hepatitis B	2.22e-06	5.22e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—hepatitis B	2.18e-06	5.14e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TP53—hepatitis B	2.11e-06	4.96e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TP53—hepatitis B	2.03e-06	4.78e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—hepatitis B	1.93e-06	4.54e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTEN—hepatitis B	1.86e-06	4.38e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—hepatitis B	1.86e-06	4.37e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TP53—hepatitis B	1.8e-06	4.23e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—hepatitis B	1.64e-06	3.87e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALB—hepatitis B	1.5e-06	3.54e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTEN—hepatitis B	1.15e-06	2.7e-06	CbGpPWpGaD
